$2200 | SAVE $300 | Single User
$4400 | SAVE $600 | Site License
$6600 | SAVE $900 | Enterprise License

Streptococcal Infections Global Clinical Trials Review, H2, 2015
[Published by Global Data]

Published by Global Data: 30 Dec 2015 | 17936 | In Stock
Related Topics: Clinical Trials

Introduction

Streptococcal Infections Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Streptococcal Infections Global Clinical Trials Review, H2, 2015" provides an overview of Streptococcal Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Streptococcal Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Streptococcal Infections Global Clinical Trials Review, H2, 2015 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

    Top Five Countries Contributing to Clinical Trials in Europe 11

    Top Countries Contributing to Clinical Trials in North America 12

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

    Top Countries Contributing to Clinical Trials in Central and South America 14

    Clinical Trials by G7 Countries: Proportion of Streptococcal Infections to Infectious Disease Clinical Trials 15

    Clinical Trials by Phase in G7 Countries 16

    Clinical Trials in G7 Countries by Trial Status 17

    Clinical Trials by E7 Countries: Proportion of Streptococcal Infections to Infectious Disease Clinical Trials 18

    Clinical Trials by Phase in E7 Countries 19

    Clinical Trials in E7 Countries by Trial Status 20

    Clinical Trials by Phase 21

    In Progress Trials by Phase 22

    Clinical Trials by Trial Status 23

    Clinical Trials by End Point Status 24

    Subjects Recruited Over a Period of Time 25

    Clinical Trials by Sponsor Type 26

    Prominent Sponsors 27

    Top Companies Participating in Streptococcal Infections Therapeutics Clinical Trials 28

    Prominent Drugs 30

    Clinical Trial Profile Snapshots 31

    Appendix 71

    Abbreviations 71

    Definitions 71

    Research Methodology 72

    Secondary Research 72

    About GlobalData 73

    Contact Us 73

    Disclaimer 73

    Source 74

List Of Tables
in Streptococcal Infections Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Tables

Streptococcal Infections Therapeutics, Global, Clinical Trials by Region, 2015* 6

Streptococcal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Streptococcal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Streptococcal Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Streptococcal Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Streptococcal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Streptococcal Infections Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Streptococcal Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Streptococcal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Streptococcal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Streptococcal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Streptococcal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 26

Streptococcal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Streptococcal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29

Streptococcal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

List Of Figures, Charts and Diagrams
in Streptococcal Infections Global Clinical Trials Review, H2, 2015 [Published by Global Data]

List of Figures

Streptococcal Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 6

Streptococcal Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7

Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Streptococcal Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Streptococcal Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Streptococcal Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Streptococcal Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Streptococcal Infections Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 15

Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Streptococcal Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Streptococcal Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 18

Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Streptococcal Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Streptococcal Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Streptococcal Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Streptococcal Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Streptococcal Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Streptococcal Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 25

Streptococcal Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 26

Streptococcal Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 27

Streptococcal Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 28

Streptococcal Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30

GlobalData Methodology 72

Additional Details

Publisher

Global Data

Publisher Information

Reference

17936 | GDHC3179CTIDB

Number of Pages

74

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 12% today! Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group A Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,262 (normally
USD $5,980)
More Info
SAVE 12% today! Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 2028
Report Summary"Group B Streptococcal Infection- Market Insights, Epidemiology and Market Forecast 20...
26 Jul 2019 by MIReports USD $5,262 (normally
USD $5,980)
More Info
SAVE 12% today! 2019 Streptococcal Infections Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Streptococcal Infections Clinical Trials Study” provides com...
24 Apr 2019 by VPA Research USD $1,583 (normally
USD $1,799)
More Info
SAVE 12% today! Streptococcal Infections Global Clinical Trials Review, H2, 2018
Streptococcal Infections Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial r...
31 Aug 2018 by Global Data USD $2,200 (normally
USD $2,500)
More Info
SAVE 12% today! Streptococcal Infections-API Insights, 2017
The active pharmaceutical ingredients worldwide market is in continuous development from the recent ...
30 May 2017 by Delve Insight USD $1,100 (normally
USD $1,250)
More Info
SAVE 12% today! Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Streptococcal Infections-Global API Manufacturers, Marketed and Phase III Dr...
30 May 2017 by Delve Insight USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Streptococcal Pneumonia - Pipeline Review, H2 2016
Streptococcal Pneumonia - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutic...
21 Dec 2016 by Global Markets Direct USD $1,760 (normally
USD $2,000)
More Info
SAVE 12% today! Ampicillin Market Analysis: by Applications (Respiratory Tract Infection, Urinary Tract Infection, Meningitis, Salmonella Infections, Endocarditis, Others (Group 3 Streptococcal Infection, etc.)) Intake Method (by Mouth, by Injection into a Muscle, Intravenously) Target Bacteria Type (Gram Positive Bacteria, Gram Negative Bacteria)-Forecast(2016-2021)
Ampicillin, a semi-synthetic derivative of penicillin, causes cell death by interfering directly wit...
25 Jan 2016 by USD $4,620 (normally
USD $5,250)
More Info

This report is published by Global Data

Download Free Report Summary PDF

Streptococcal Infections Global Clinical Trials Review, H2, 2015 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...